Adenocarcinoma of the Pancreas Recruiting Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT036788839-ING-41 in Patients With Advanced CancersTreatment
NCT03193190A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)Treatment
NCT04060342GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaTreatment